Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elke Theander

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Journal of Immunological Methods|January 29, 2017
Efficient evaluation of humoral immune responses by the use of serum poolsLouise Sternbæk, Anette H Draborg, Christoffer T Nielsen, et al.
Rheumatology Advances in Practice|February 19, 2021
Corrigendum to: Persistence of biologic treatments in psoriatic arthritis: a population-based study in SwedenKirk Geale, Ingrid Lindberg, Emma C Paulsson, et al.
Rheumatology Advances in Practice|January 7, 2021
Persistence of biologic treatments in psoriatic arthritis: a population-based study in SwedenKirk Geale, Ingrid Lindberg, Emma C Paulsson, et al.
The Journal of Rheumatology|June 17, 2020
Mixed Airway and Pulmonary Parenchymal Disease in Patients With Primary Sjögren Syndrome: A 6-year Follow-upAnna Matilda Nilsson, H Laura Aaltonen, Peter Olsson, et al.
Annals of the Rheumatic Diseases|July 1, 2011
Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndromeElke Theander, Lilian Vasaitis, Eva Baecklund, et al.
Arthritis Research & Therapy|June 9, 2023
Response to treatment in psoriatic arthritis, the effect of age: analysis of patients receiving ustekinumab in the PsABio real-world studyLaure Gossec, Elke Theander, Soumya D Chakravarty, et al.
Rheumatology and Therapy|December 30, 2022
PsABIOnd Study and eDaily Substudy Design: Long-Term Effectiveness and Safety of Guselkumab and IL-17 Inhibitors in Routine Clinical Practice in Patients with Psoriatic ArthritisStefan Siebert, Frank Behrens, Ennio Lubrano, et al.
Rheumatology International|May 30, 2019
Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjögren's syndromePeter Olsson, Iris L A Bodewes, Anna M Nilsson, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|February 8, 2019
Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathologyLouise Sternbæk, Anette H Draborg, Mark T Østerlund, et al.
Annals of the Rheumatic Diseases|June 30, 2009
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndromeRaphaèle Seror, Philippe Ravaud, Simon J Bowman, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Journal of Immunological Methods|January 29, 2017
Efficient evaluation of humoral immune responses by the use of serum poolsLouise Sternbæk, Anette H Draborg, Christoffer T Nielsen, et al.
Rheumatology Advances in Practice|February 19, 2021
Corrigendum to: Persistence of biologic treatments in psoriatic arthritis: a population-based study in SwedenKirk Geale, Ingrid Lindberg, Emma C Paulsson, et al.
Rheumatology Advances in Practice|January 7, 2021
Persistence of biologic treatments in psoriatic arthritis: a population-based study in SwedenKirk Geale, Ingrid Lindberg, Emma C Paulsson, et al.
The Journal of Rheumatology|June 17, 2020
Mixed Airway and Pulmonary Parenchymal Disease in Patients With Primary Sjögren Syndrome: A 6-year Follow-upAnna Matilda Nilsson, H Laura Aaltonen, Peter Olsson, et al.
Annals of the Rheumatic Diseases|July 1, 2011
Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndromeElke Theander, Lilian Vasaitis, Eva Baecklund, et al.
Arthritis Research & Therapy|June 9, 2023
Response to treatment in psoriatic arthritis, the effect of age: analysis of patients receiving ustekinumab in the PsABio real-world studyLaure Gossec, Elke Theander, Soumya D Chakravarty, et al.
Rheumatology and Therapy|December 30, 2022
PsABIOnd Study and eDaily Substudy Design: Long-Term Effectiveness and Safety of Guselkumab and IL-17 Inhibitors in Routine Clinical Practice in Patients with Psoriatic ArthritisStefan Siebert, Frank Behrens, Ennio Lubrano, et al.
Rheumatology International|May 30, 2019
Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjögren's syndromePeter Olsson, Iris L A Bodewes, Anna M Nilsson, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|February 8, 2019
Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathologyLouise Sternbæk, Anette H Draborg, Mark T Østerlund, et al.
Annals of the Rheumatic Diseases|June 30, 2009
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndromeRaphaèle Seror, Philippe Ravaud, Simon J Bowman, et al.
Pageof 8